Clinical Trial Update: A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction [Phase 1]

View source ↗

Summary

Phase 1 trial of LY3461767 in patients with heart failure with reduced ejection fraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• LY3461767

Snippet

Sponsor: Eli Lilly and Company | Conditions: Chronic Heart Failure With Reduced Ejection Fraction | Phase 1 | Status: COMPLETED